Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult
- PMID: 33181855
- DOI: 10.4414/smw.2020.20387
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult
Abstract
A 22-year-old male with a typical history of pauci-symptomatic COVID-19 3 weeks earlier, confirmed by positive serology for SARS-CoV-2 (IgG), was admitted to the intensive care unit because of severe myocarditis with refractory cardiogenic shock that required extracorporeal life support. Due to a clinical presentation suggestive of Kawasaki-like disease with coronary aneurysm and severe systemic inflammation, intravenous immunoglobulins were administered in combination with tocilizumab. The initial clinical course was favourable with these treatments. However, the patient subsequently developed a severe mononeuritis multiplex leading to bilateral foot drop, which required intensive immunosuppressive therapy (corticosteroids, cyclophosphamide and rituximab). The clinical presentation meets the criteria for multisystem inflammatory syndrome associated with SARS-CoV-2, but includes very severe organ damages. Early recognition, a multidisciplinary approach and aggressive therapeutic intervention can lead to a favourable outcome.
Similar articles
-
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic.Circulation. 2020 Aug 4;142(5):429-436. doi: 10.1161/CIRCULATIONAHA.120.048360. Epub 2020 May 17. Circulation. 2020. PMID: 32418446
-
Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic - reports of three adolescents.Bosn J Basic Med Sci. 2021 Apr 1;21(2):252. doi: 10.17305/bjbms.2020.5037. Bosn J Basic Med Sci. 2021. PMID: 33119481 Free PMC article.
-
Cardiogenic shock complicating multisystem inflammatory syndrome following COVID-19 infection: a case report.BMC Cardiovasc Disord. 2021 Oct 29;21(1):522. doi: 10.1186/s12872-021-02304-y. BMC Cardiovasc Disord. 2021. PMID: 34715788 Free PMC article.
-
Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.Arch Cardiovasc Dis. 2021 May;114(5):426-433. doi: 10.1016/j.acvd.2021.04.005. Epub 2021 May 24. Arch Cardiovasc Dis. 2021. PMID: 34052147 Free PMC article. Review.
-
Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.J Intensive Care Med. 2021 Apr;36(4):392-403. doi: 10.1177/0885066620969350. Epub 2020 Nov 5. J Intensive Care Med. 2021. PMID: 33148089 Review.
Cited by
-
Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.Sci Rep. 2021 Nov 8;11(1):21872. doi: 10.1038/s41598-021-01410-3. Sci Rep. 2021. PMID: 34750486 Free PMC article.
-
Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review.JAMA Netw Open. 2021 Sep 1;4(9):e2126456. doi: 10.1001/jamanetworkopen.2021.26456. JAMA Netw Open. 2021. PMID: 34550381 Free PMC article.
-
The impact that myocarditis for post-acute COVID-19 syndrome may be dermatomyositis-like myocarditis: A case report.Heliyon. 2023 May 25;9(6):e16512. doi: 10.1016/j.heliyon.2023.e16512. eCollection 2023 Jun. Heliyon. 2023. PMID: 37255981 Free PMC article.
-
Putative mechanisms explaining neuro-COVID.J Neuroimmunol. 2020 Dec 2;350:577453. doi: 10.1016/j.jneuroim.2020.577453. Online ahead of print. J Neuroimmunol. 2020. PMID: 33333470 Free PMC article. No abstract available.
-
The emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: A systematic review.Heart Lung. 2022 Jul-Aug;54:7-18. doi: 10.1016/j.hrtlng.2022.03.007. Epub 2022 Mar 14. Heart Lung. 2022. PMID: 35306376 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous